Winton Group’s Immunomedics Inc IMMU Stock Holding History

Winton Group’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-95,241	Closed	-$8.1M	–	1613
2020 Q3	$8.1M	Buy	+95,241	New	+$4.82M	0.26%	36
2019 Q1	–	Sell	-21,852	Closed	-$312K	–	1231
2018 Q4	$312K	Sell	21,852 -4,499	-17%	-$89.3K	0.01%	645
2018 Q3	$549K	Buy	26,351 +9,137	+53%	+$216K	0.01%	589
2018 Q2	$407K	Sell	17,214 -8,992	-34%	-$181K	0.01%	716
2018 Q1	$383K	Buy	+26,206	New	+$428K	0.01%	887

Winton Group's IMMU Position: Q4 2020 in Review

Winton Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 95,241 shares — an estimated $8.1M sold.

Winton Group first reported a position in IMMU in Q1 2018 and held it in 5 quarters. The position peaked at $8.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Winton Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Winton Group sold 95,241 Immunomedics Inc shares in Q4 2020, an estimated $8.1M.
Winton Group first reported a position in Immunomedics Inc in Q1 2018 and held it in 5 quarters.
Winton Group's Immunomedics Inc position peaked at $8.1M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Winton Group's 13F filing for Q4 2020, filed 12 Feb 2021.